Table 1 Demographic, clinical, and tumour characteristics of patients with hepatocellular carcinoma.

  <60

150

88

263

0.68

  ≥60

45

26

92

 Sex (male), n (%)

158 (81.0%)

96 (84.2%)

306 (86.2%)

0.28

 HBV

163

95

298

0.51

 Liver cirrhosis, yes (%)

155 (79.5%)

89 (78.1%)

302 (85.1%)

0.12

 AFP, ng/ml

76.0 (6.0, 807.0)

120.5 (5.3, 675.0)

77.0 (5.0, 861.5)

0.86

 Albumin, g/dl

4.2 (3.9, 4.6)

4.4 (4.1, 4.6)

4.4 (4.0, 4.7)

0.02

 Bilirubin, μmol/l

15.1 (11.9, 19.0)

15.0 (11.7, 19.4)

14.1 (10.5, 18.4)

0.05

 ALT, IU/l

41.0 (27.5, 67.5)

41.0 (27.5, 57.5)

38.0 (26.0, 52.0)

0.10

 GGT, U/l

53.0 (34.0, 100.0)

50.0 (30.3, 95.5)

57.0 (37.0, 99.0)

0.22

 Tumour diameter, cm

4.0 (2.5, 6.0)

4.0 (2.5, 7.0)

3.5 (2.5, 6.0)

0.41

 Microvascular invasion (yes), n (%)

62 (31.8%)

32 (28.1%)

98 (27.6%)

0.57

  I–II

147

87

253

0.42

  III–IV

48

27

102

CGLC stage

0.30

  Ia

128

76

254

  Ib

67

38

101

  0

29

13

46

0.67

  A

166

101

309